Tad-600 Dosage/Direction for Use

The daily dose of Glutathione usually recommended for patients undergoing chemotherapy is 1.5 g/m² (corresponding to 2500 mg) administered by slow intravenous infusion. The dosage however is dependent on age, weight and clinical conditions of the patient and should also be related to the dose and the administered schedule of the chemotherapeutic agent. In case of long term treatment, the lower dosages of the product can be employed (300 mg or 600 mg) to be administered by intramuscular route or slowly by the intravenous route or as prescribed by the physicians.
Direction for Reconstitution: Reconstitute the solution in the powder vial by drawing the sterile water of the ampoule by means of a syringe with an appropriate needle. Remove the aluminum seal of the vial and wipe closures with disinfectant, then insert the needle of the syringe in the vial through the center of the rubber closure and direct the flow of water toward the glass wall of the vial. Gently shake to ensure the complete solubilization, then administer the solution thus obtained by intramuscular or slow intravenous route. The reconstituted solution contains 150 mg/mL of glutathione. The reconstituted solution is stable for 8 hours at temperatures not exceeding 25°C. The reconstituted solution should be clear and devoid of visible particles. It should be used only for one uninterrupted administration and the incidental residue should not be employed.